Detalhe da pesquisa
1.
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.
N Engl J Med
; 386(22): 2084-2096, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507508
2.
Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies.
Infect Dis Ther
; 12(2): 411-423, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36520325
3.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.
medRxiv
; 2023 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523415
4.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.
Lancet Respir Med
; 11(11): 975-990, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37716365
5.
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
EClinicalMedicine
; 62: 102109, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533419
6.
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.
EClinicalMedicine
; 64: 102168, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936652
7.
Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine.
Vaccine
; 40(6): 904-911, 2022 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991926
8.
Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19.
Nat Commun
; 13(1): 6905, 2022 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36371408
9.
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy.
Vaccine
; 40(32): 4503-4512, 2022 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717267
10.
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities.
NPJ Vaccines
; 7(1): 142, 2022 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351931
11.
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial.
EClinicalMedicine
; 51: 101569, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879941
12.
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Lancet Infect Dis
; 22(5): 636-648, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090638
13.
Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.
Vaccine
; 39(11): 1598-1608, 2021 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33612341
14.
Immune interference (blunting) in the context of maternal immunization with Tdap-containing vaccines: is it a class effect?
Expert Rev Vaccines
; 19(4): 341-352, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32237928
15.
A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis.
Expert Rev Vaccines
; 19(7): 621-638, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32772755
16.
Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial.
Vaccine
; 38(8): 2105-2114, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776027
17.
Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial.
Vaccine
; 38(8): 2095-2104, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776029